← Browse by Condition
Medical Condition

non hodgkins lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2

ClinicalMetric aggregates all active clinical trials for non hodgkins lymphoma from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT04728893 Phase 2
Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Enrollment
490 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
View Trial →